Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown. - De Luca I; Di Carlo F; Burkauskas J; Dores AR; Carvalho IP; Gómez-Martínez MÁ; Szabo A; Fujiwara H; Barbosa CM; Di Nicola M; Mazza M; Sani G; et al. (Frontiers in public health, 2024)